Skip to main content

Table 3 Patient characteristics

From: A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer

Variables

Values

SD

Age (y.o.)

71.9

4.74

iPSA (ng/mL)

7.94

3.66

Gleason score

 3 + 3

11

 

 3 + 4

6

 

 4 + 3

10

 

T stage

 1c

12

 

 2a

11

 

 2b

3

 

 2c

1

 

Positive cores (%)

32.2

29.3

Hormonal therapy

 Yes

10

 

 No

17

 

CTV (cm3)

47.7

22.7

PTV (cm3)

96.9

35.4

  1. Abbreviations: iPSA initial prostate specific antigen, SD Standard deviation, CTV Clinical target volume, PTV Planning target volume, Values are mean or number
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us